tirzepatide insulin sensitivity for Medical Weight Loss in Northglenn, CO How Tirzepatide Can Help You

Liposomal technology ensures the molecule reaches your cells intact

All authors read and approved the final manuscript

Not intended for human or animal consumption, medical, cosmetic, or household applications

Month 2-3: Step-up dosing, adjusted for tolerance

SURMOUNT-1 Trial Results (Published in New England Journal of Medicine): According to the SURMOUNT-1 clinical trial enrolling 2,539 participants, tirzepatide achieved the following mean weight reductions at 72 weeks: 5 mg dose: 16.0% mean weight loss (approximately 35 lbs or 16 kg) 10 mg dose: 21.4% mean weight loss (approximately 49 lbs or 22 kg) 15 mg dose: 22.5% mean weight loss (approximately 52 lbs or 24 kg) Placebo: 2.4% mean weight loss (approximately 5 lbs or 2 kg) According to the trial data, 89% to 96% of participants taking tirzepatide at the 10 mg and 15 mg doses achieved at least 5% body weight reduction, compared to 28% of those taking placebo